About TREOVIR INC
Treovir Inc. is a biotechnology company focused on developing therapies for pediatric brain tumors, with a Phase 2 clinical trial for their G207 therapy in progress. They aim to provide effective treatments with minimal side effects for an incurable disease with no approved therapies.
Development of therapies for pediatric brain tumorsConducting clinical trialsPhase 2 clinical study for G207 in recurrent glioblastoma
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to TREOVIR INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.